WEGO Medical is pleased to announce its participation in WHX Dubai 2026, formerly known as Arab Health, one of the most influential global healthcare exhibitions.
Cardioplegia Delivery
WEGO Medical
For myocardial protection during open heart surgery.
WEGONODEHP
Cardioplegia Delivery
Type A requires the use of a heat exchange water tank and is currently the only product in China that has obtained registration qualifications.
Type B uses a mixture of ice and water.
Piping can be configured according to customer requirements.
Overview
WEGO Cardioplegia delivery system is a medical instrument specifically designed for open-heart surgery, primarily used to provide effective myocardial protection during the procedure.
This device ensures the precise delivery of cardioplegia solution, enabling rapid cardiac arrest and creating a clear and stable surgical field for the operation. Additionally, it helps reduce the risk of myocardial ischemic injury, protects myocardial cell viability, and promotes the recovery of cardiac function after surgery.
As a single-use product, the perfusion device offers high sterility, ease of operation, and strong safety, effectively reducing the risk of infection and enhancing both surgical quality and patient outcomes.
Specifications
Specifications
| Category | Maximum Flow Rate (L/min) | Membrane Area (m²) | Priming Volume (Excluding Tubing) (ml) | Filter Pore Size (µm) | |
| Blood-Crystalloid Type | A Type | 0.5 | 0.2 | ≤30 | 150 |
| B Type | 0.5 | — | — | — | |
| Single-Crystalloid Type | A Type | 0.5 | 0.2 | ≤30 | — |
| B Type | 0.5 | — | — | — | |
Documents
Product Details
certificate
News
Read More »
As the new year begins, WEGO Overseas Group would like to extend our warmest New Year greetings to partners, customers, and colleagues around the world.
From all of us at WEGO, we extend our warmest wishes to our global partners and customers. May this festive season bring joy, peace, and
In cardiac surgery, maintaining proper oxygenation of blood is critical for patient safety and successful outcomes. Membrane oxygenators, often referred to as oxygenators for CPB (cardiopulmonary
